Graphene-Based Nanoparticles as Potential Treatment Options for Parkinson’s Disease: A Molecular Dynamics Study
Ehsan Alimohammadi1 *,* Mohammad Khedri2 *,* Ahmad Miri Jahromi,3 Reza Maleki,4 Milad Rezaian5 1Neurosurgery Department, Kermanshah University of Medical Sciences, Kermanshah, Iran; 2Department of Chemical Engineering, Amirkabir University of Technology (Tehran Polytechnic), Tehran 1591634311, Iran;...
Guardado en:
Autores principales: | Alimohammadi E, Khedri M, Miri Jahromi A, Maleki R, Rezaian M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4c5d27800dc146e7a035a35350cb76e3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effect of superparamagnetic nanoparticles coated with various electric charges on α-synuclein and β-amyloid proteins fibrillation process
por: Javdani N, et al.
Publicado: (2019) -
Association between Sleep, Alzheimer’s, and Parkinson’s Disease
por: Sumire Matsumoto, et al.
Publicado: (2021) -
CK1BP Reduces α-Synuclein Oligomerization and Aggregation Independent of Serine 129 Phosphorylation
por: Lea Elsholz, et al.
Publicado: (2021) -
Missense Mutations Modify the Conformational Ensemble of the α-Synuclein Monomer Which Exhibits a Two-Phase Characteristic
por: Adrien Guzzo, et al.
Publicado: (2021) -
α-synuclein interaction with zero-valent iron nanoparticles accelerates structural rearrangement into amyloid-susceptible structure with increased cytotoxic tendency
por: Tahaei Gilan SS, et al.
Publicado: (2019)